Yuan Xiandao, Fang Jugao, Wang Li, Yao Linyin, Li Li, Zhan Xiaojun, Wu Hao, Pinto Jayant M, Wei Yongxiang
Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, No. 2nd, Anzhen Road, Beijing, 100029, China.
Sleep Breath. 2015 Sep;19(3):911-20. doi: 10.1007/s11325-014-1091-9. Epub 2014 Dec 9.
Severe obstructive sleep apnea (OSA) is a risk factor for mortality. The ability of continuous positive airway pressure (CPAP) therapy to mitigate this increased risk of death has not been studied in Chinese adults. The objective of our study was to compare mortality in Chinese patients with simple snoring, untreated OSA, and OSA treated with CPAP.
We recruited adults with OSA or simple snoring from our sleep medicine clinic. OSA was diagnosed using standard polysomnography. Subjects were followed at least annually for a mean of 8.9 years (SD 1.9). CPAP compliance was checked with the built-in meter. We then assessed all-cause mortality.
Five hundred fifty simple snorers, 257 with untreated mild OSA, 316 with untreated moderate OSA, 457 with untreated severe OSA, and 235 with mild to severe OSA treated with CPAP were included. Simple snorers had a much lower mortality rate (2.98 per 1000 person-years [95% CI, 2.93 to 3.02]) than the untreated severe OSA group (11.07 per 1000 person-years [95%CI, 10.86 to 11.29]; P < 0.0001). Compared with simple snorers, fully adjusted mortality was highest in the untreated, severe OSA group (hazard ratio [HR], 3.51 [95%CI, 1.93 to 6.39]). Treatment of severe OSA patients with CPAP eliminated this increase in mortality (HR, 0.81[95%CI, 0.36-1.86]).
Severe OSA significantly markedly increases the risk of death in Chinese patients and CPAP treatment with adequate compliance reduces this risk.
重度阻塞性睡眠呼吸暂停(OSA)是死亡的一个危险因素。持续气道正压通气(CPAP)治疗减轻这种死亡风险增加的能力在中国成年人中尚未得到研究。我们研究的目的是比较中国单纯打鼾患者、未经治疗的OSA患者和接受CPAP治疗的OSA患者的死亡率。
我们从睡眠医学诊所招募了患有OSA或单纯打鼾的成年人。使用标准多导睡眠图诊断OSA。对受试者进行至少每年一次的随访,平均随访8.9年(标准差1.9)。使用内置仪表检查CPAP依从性。然后我们评估全因死亡率。
纳入了550名单纯打鼾者、257名未经治疗的轻度OSA患者、316名未经治疗的中度OSA患者、457名未经治疗的重度OSA患者以及235名接受CPAP治疗的轻至重度OSA患者。单纯打鼾者的死亡率(每1000人年2.98例[95%CI,2.93至3.02])远低于未经治疗的重度OSA组(每1000人年11.07例[95%CI,10.86至11.29];P<0.0001)。与单纯打鼾者相比,未经治疗的重度OSA组完全调整后的死亡率最高(风险比[HR],3.51[95%CI,1.93至6.39])。用CPAP治疗重度OSA患者消除了死亡率的这种增加(HR,0.81[95%CI,0.36 - 1.86])。
重度OSA显著增加中国患者的死亡风险,而依从性良好的CPAP治疗可降低这种风险。